Rani Therapeutics CTO Javadi Alireza Withholds 309 Shares for Taxes

What Happened Javadi Alireza, Chief Technical Officer of Rani Therapeutics (RANI), had 309 shares withheld and surrendered to the company to satisfy tax withholding obligations related to the settlement and release of restricted stock units (RSUs). The filing reports the shares at $0.76 each, for a notional value of approximately $235. This was a tax-withholding disposition (code F), not an open-market sale.

Key Details

• Transaction date: 2026-09-27; SEC filing date: 2026-09-29.
• Shares involved: 309; Price per share reported: $0.76; Total value: ~$235.
• Post-transaction holdings: Not specified in the provided excerpt.
• Footnote: F1 — shares were withheld and surrendered to the issuer to satisfy tax withholding on RSUs.
• Filing timeliness: Reported two days after the transaction (no late-filing flag provided here).

Context Tax-withholding dispositions are routine when RSUs vest and do not indicate a traditional sale or a change in insider sentiment. The insider surrendered company shares to cover tax obligations (a common cashless settlement method), so this should be viewed as a payroll/tax action rather than a directional bet on the stock.